An Evening With Sol Spiegelman: The Creativity Dispute

[Editor's note: Is the work of a scientist creative by nature? Or, is the scientist's function to reflect reality by mirroring nature in a series of experiments reproducible by others? How does one measure the value of contributions made by any one scientist? By how well a particular researcher is remembered after he or she is dead? By the number of accolades and honors accrued? Or by the number of other scientists inspired by the researcher's work? These are among the questions world-renown

Written byGeorge Klein
| 13 min read

Register for free to listen to this article
Listen with Speechify
0:00
13:00
Share

[Editor's note: Is the work of a scientist creative by nature? Or, is the scientist's function to reflect reality by mirroring nature in a series of experiments reproducible by others? How does one measure the value of contributions made by any one scientist? By how well a particular researcher is remembered after he or she is dead? By the number of accolades and honors accrued? Or by the number of other scientists inspired by the researcher's work? These are among the questions world-renowned Swedish biomedical scientist George Klein raises as he reminisces about a visit with the late cancer researcher Sol Spiegelman, an American molecular biologist legendary for his laboratory productivity and willingness to aggressively investigate the longest of scientific long shots. In 1936, for example, Spiegelman, trained in both mathematics and biology, began to study bacteria in search of an understanding of cell genetics. This was indeed a revolutionary ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies